Abstract:Inhibition of transient receptor potential vanilloid 1 (TRPV1) significantly reduced brain tissue damage and cerebral inflammation and limited neurodegeneration after ICH. Inhibition of TRPV1 attenuated hemin‐induced apoptosis and preserved mitochondrial integrity by reducing Ca2+ influx and CaMKII‐P38 and c‐Jun NH2‐terminal kinase mitogen‐activated protein kinase signaling in vitro. Inhibition of TRPV1 may protect against ICH‐induced brain injury by modulating mitochondria‐related neuronal apoptosis and inflammatory responses. Intracerebral hemorrhage (ICH) induces a complex sequence of apoptotic cascades and inflammatory responses, leading to neurological impairment. Transient receptor potential vanilloid 1 (TRPV1), a nonselective cation channel with high calcium permeability, has been implicated in neuronal apoptosis and inflammatory responses. This study used a mouse ICH model and neuronal cultures to examine whether TRPV1 activation exacerbates brain damage and neurological deficits by promoting neuronal apoptosis and neuroinflammation. ICH was induced by injecting collagenase in both wild‐type (WT) C57BL/6 mice and TRPV1−/− mice. Capsaicin (CAP; a TRPV1 agonist) or capsazepine (a TRPV1 antagonist) was administered by intracerebroventricular injection 30 min before ICH induction in WT mice. The effects of genetic deletion or pharmacological inhibition of TRPV1 using CAP or capsazepine on motor deficits, histological damage, apoptotic responses, blood–brain barrier (BBB) permeability, and neuroinflammatory reactions were explored. The antiapoptotic mechanisms and calcium influx induced by TRPV1 inactivation were investigated in cultured hemin‐stimulated neurons. TRPV1 expression was upregulated in the hemorrhagic brain, and TRPV1 was expressed in neurons, microglia, and astrocytes after ICH. Genetic deletion of TRPV1 significantly attenuated motor deficits and brain atrophy for up to 28 days. Deletion of TRPV1 also reduced brain damage, neurodegeneration, microglial activation, cytokine expression, and cell apoptosis at 1 day post‐ICH. Similarly, the administration of CAP ameliorated brain damage, neurodegeneration, brain edema, BBB permeability, and cytokine expression at 1 day post‐ICH. In primary neuronal cultures, pharmacological inactivation of TRPV1 by CAP attenuated neuronal vulnerability to hemin‐induced injury, suppressed apoptosis, and preserved mitochondrial integrity in vitro. Mechanistically, CAP reduced hemin‐stimulated calcium influx and prevented the phosphorylation of CaMKII in cultured neurons, which was associated with reduced activation of P38 and c‐Jun NH2‐terminal kinase mitogen‐activated protein kinase signaling. Our results suggest that TRPV1 inhibition may be a potential therapy for ICH by suppressing mitochondria‐related neuronal apoptosis.

Elevated TRPV4 Levels Contribute to Endothelial Damage and Scarring in Experimental Spinal Cord Injury

The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat

TRPV1 participates in neuropathic pain after spinal cord injury by mediating the proliferation and activation of CX3CL1-positive glial cells in the spinal dorsal horn

An electrophysiological study about the pharmacological manipulation of the immediate consequences of a spinal trauma reveals a crucial role for TRPV4 antagonism.

TRPV4 Blockade Preserves the Blood–Brain Barrier by Inhibiting Stress Fiber Formation in a Rat Model of Intracerebral Hemorrhage

TRPV4-Mediated Regulation of the Blood Brain Barrier Is Abolished During Inflammation

TRPM7 Mediates Neuropathic Pain by Activating mTOR Signaling in Astrocytes after Spinal Cord Injury in Rats

Transient receptor potential vanilloid 1 inhibition reduces brain damage by suppressing neuronal apoptosis after intracerebral hemorrhage

Activation of Transient Receptor Potential Vanilloid 4 Involves in Hypoxia/reoxygenation Injury in Cardiomyocytes

Selective Sensory Axon Reinnervation and TRPV1 Activation

Transient receptor potential vanilloid 4 regulates extracellular matrix composition and mediates load-induced intervertebral disc degeneration in a mouse model

Inhibition of Transient Receptor Potential Vanilloid 1 Attenuates Blood-Brain Barrier Disruption after Traumatic Brain Injury in Mice

TRPV4 Activation Contributes Functional Recovery from Ischemic Stroke via Angiogenesis and Neurogenesis

Role of Nonneuronal TRPV4 Signaling in Inflammatory Processes

Dual Role of TRPV1 Channels in Cerebral Stroke: An Exploration from a Mechanistic and Therapeutic Perspective

A TRPV4-dependent Neuroimmune Axis in the Spinal Cord Promotes Neuropathic Pain

Role of TRPV4 channel in vasodilation and neovascularization

Different TLR4 Expression and Microglia/macrophage Activation Induced by Hemorrhage in the Rat Spinal Cord after Compressive Injury.

TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury

Inhibition of Intracellular Proton-Sensitive Ca2+-permeable TRPV3 Channels Protects Against Ischemic Brain Injury.

TRPM7 Mediates BSCB Disruption After Spinal Cord Injury by Regulating the mTOR/JMJD3 Axis in Rats